Prevention of nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults and paediatric patients aged 6 months and older. IVEMEND 150 mg is given as part of a combination therapy (see section 4.2).
ViiV Healthcare presented at the 22nd International AIDS conference in Amsterdam 48-week results from the phase III GEMINI 1 &...
NINLARO in combination with lenalidomide and dexamethasone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.